Dr Graham P Taylor

Publications


Journals

  • Byrne L; de Alwis O; Toby M; Shah R; Hartley A; Umaipalan A; Short C-E; Murphy S; et alOomer S; de Ruiter A; Noble H; Anderson J; Kapembwa M; Taylor G; Sarner L. (1 Apr 2012). Managing the pregnancies of HIV elite controllers: what are we doing?. HIV MEDICINE. 13:1-1. Author weblink.
  • Charlton TG; Franklin JM; Douglas M; Short CE; Mills I; Smith R; Clarke A; Tookey PA; et alCortina-Borja M; Smith J; Taylor G. (1 Apr 2012). The impact of HIV infection and antiretroviral therapy on the predicted risk of Down's syndrome. HIV MEDICINE. 13:2-2. Author weblink.
  • Rosenvinge M; Dosekun O; Rodgers M; Ramsay S; Perez K; Foster R; Shah R; Hughes A; et alWhetham J; Sundaram S; Lowe S; Umaipalan A; Roedling S; Schroeder K; Russell J; Kegg S; Mcquillain O; Kingston M; Taylor G; Hawkins D; Gilleece Y; Mani R; Sarner L; Anderson J; Estreich S; McKeown D; De Ruiter A; Hay P. (1 Apr 2012). A multicentre case series of Raltegravir use in pregnancy. HIV MEDICINE. 13:1-1. Author weblink.
  • Chen L-J; Ford T; Metcalf R; Smith J; Taylor G; Croucher A; Smith C; Fidler S; et alReid S. (1 Apr 2012). Validation of point-of-care CD4 tests in pregnancy. HIV MEDICINE. 13:60-61. Author weblink.
  • Huntington S; Thorne C; Anderson J; Newell M-L; Taylor G; Pillay D; Hill T; Tookey P; et alSabin C. (1 Apr 2012). Pregnancies among women seen for HIV-clinical care - predictors and trends over time. HIV MEDICINE. 13:35-36. Author weblink.
  • Tipple C; Taylor G. (1 Jul 2011). DECIPHERING THE CODE OF TREPONEMA PALLIDUM IN THE UK: IMPLICATIONS FOR TREATMENT AND PREVENTION. SEXUALLY TRANSMITTED INFECTIONS. 87:A69-A70. Author weblink DOI.
  • Pollock KM; Tam H; Grass L; Bowes S; Cooke GS; Pareek M; Montamat-Sicotte D; Kapembwa M; et alTaylor GP; Lalvani A. (2012). Comparison of screening strategies to improve the diagnosis of latent tuberculosis infection in the HIV-positive population: a cohort study. BMJ Open. 2:e000762. DOI.
  • Else LJ; Douglas M; Dickinson L; Back DJ; Khoo SH; Taylor GP. (1 Feb 2012). Improved Oral Bioavailability of Lopinavir in Melt-Extruded Tablet Formulation Reduces Impact of Third Trimester on Lopinavir Plasma Concentrations. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 56:816-824. Author weblink DOI.
  • Brant LJ; Cawley C; Davison KL; Taylor GP. (17 Nov 2011). Recruiting individuals into the HTLV cohort study in the United Kingdom: clinical findings and challenges in the first six years, 2003 to 2009. EUROSURVEILLANCE. 16:7-14. Author weblink.
  • Tattermusch S; Skinner JA; Chaussabel D; Banchereau J; Berry MP; McNab FW; O'Garra A; Taylor GP; et alBangham CR. (Jan 2012). Systems biology approaches reveal a specific interferon-inducible signature in HTLV-1 associated myelopathy. PLoS Pathog. 8:e1002480. DOI.
  • Kirk PD; Witkover A; Courtney A; Lewin AM; Wait R; Stumpf MP; Richardson S; Taylor GP; et alBangham CR. (2011). Plasma proteome analysis in HTLV-1-associated myelopathy/tropical spastic paraparesis. Retrovirology. 8:81. DOI.
  • Hodson A; Crichton S; Montoto S; Mir N; Matutes E; Cwynarski K; Kumaran T; Ardeshna KM; et alPagliuca A; Taylor GP; Fields PA. (10 Dec 2011). Use of zidovudine and interferon alfa with chemotherapy improves survival in both acute and lymphoma subtypes of adult T-cell leukemia/lymphoma. J Clin Oncol. 29:4696-4701. DOI.
  • Tipple C; McClure MO; Taylor GP. (Oct 2011). High prevalence of macrolide resistant Treponema pallidum strains in a London centre. Sex Transm Infect. 87:486-488. DOI.
  • Martin F; Taylor GP. (1 Jul 2011). Prospects for the Management of Human T-cell Lymphotropic Virus Type 1-Associated Myelopathy. AIDS REVIEWS. 13:161-170.
  • Huntington SE; Bansi LK; Thorne C; Anderson J; Newell M-L; Taylor GP; Pillay D; Hill T; et alTookey PA; Sabin CA. (24 Aug 2011). Treatment switches during pregnancy among HIV-positive women on antiretroviral therapy at conception. AIDS. 25:1647-1655. DOI.
  • Taylor G; Anderson J; Clayden P; Gazzard B; Fortin J; Kennedy J; Lazarus L; Newell ML; et alOsoro B; Sellers S; Tookey P; Tudor-Williams G; Williams A; BHIVA/CHIVA Guidelines Writing Group. (Aug 2011). British HIV Association and Children's HIV Association position statement on infant feeding in the UK 2011. HIV Med. 12:389-393. DOI.
  • Taylor GP; Anderson J; Clayden P; Gazzard BG; Fortin J; Kennedy J; Lazarus L; Newell M-L; et alOsoro B; Sellers S; Tookey PA; Tudor-Williams G; Williams A; de Ruiter A. (1 Aug 2011). British HIV Association and Children's HIV Association position statement on infant feeding in the UK 2011. HIV MEDICINE. 12:389-393. DOI.
  • Tipple C; Hanna MO; Hill S; Daniel J; Goldmeier D; McClure MO; Taylor GP. (Oct 2011). Getting the measure of syphilis: qPCR to better understand early infection. Sex Transm Infect. 87:479-485. DOI.
  • Huntington SE; Bansi LK; Thorne C; Anderson J; Newell ML; Taylor GP; Pillay D; Hill T; et alTookey PA; Sabin CA; UK Collaborative HIV Cohort (UK CHIC) Study and the National Study of HIV in Pregnancy and Childhood (NSHPC). (24 Aug 2011). Treatment switches during pregnancy among HIV-positive women on antiretroviral therapy at conception. AIDS. 25:1647-1655. DOI.
  • Caswell RJ; Phillips D; Chaponda M; Khoo SH; Taylor GP; Ghanem M; Poulton M; Welch J; et alGibbons S; Jackson V; Lambert JS. (1 Jan 2011). Utility of therapeutic drug monitoring in the management of HIV-infected pregnant women in receipt of lopinavir. INTERNATIONAL JOURNAL OF STD & AIDS. 22:11-14. Author weblink DOI.
  • Macchi B; Balestrieri E; Ascolani A; Hilburn S; Martin F; Mastino A; Taylor GP. (1 May 2011). Susceptibility of Primary HTLV-1 Isolates from Patients with HTLV-1-Associated Myelopathy to Reverse Transcriptase Inhibitors. VIRUSES-BASEL. 3:469-483. Author weblink DOI.
  • Rende F; Cavallari I; Corradin A; Silic-Benussi M; Toulza F; Toffolo GM; Tanaka Y; Jacobson S; et alTaylor GP; D'Agostino DM; Bangham CR; Ciminale V. (5 May 2011). Kinetics and intracellular compartmentalization of HTLV-1 gene expression: nuclear retention of HBZ mRNAs. Blood. 117:4855-4859. DOI.
  • Pollock K; Tam H; Montamat-Sicotte D; Grass L; Cooke G; Kapembwa M; Taylor G; Lalvani A. (1 Apr 2011). Screening for latent tuberculosis infection in HIV: should we do more?. HIV MEDICINE. 12:42-42. Author weblink.
  • Fowler J; Douglas M; Taylor GP; Mackie NE. (1 Apr 2011). Safe conception: an audit of advice and methods used by HIV-positive women. HIV MEDICINE. 12:33-33. Author weblink.
  • Samuel M; Bradshaw D; Perry M; Dhairyawan R; Chan SY; Byrne L; Smith K; Zhou J; et alNaftalin C; Offodile N; Short C-E; Ratnayake G; Mandalia S; Shah R; Brook G; Roedling S; Anderson J; Hay P; Noble H; Hawkins D; Sarner L; Rodgers M; Poulton M; Cross R; Natha M; Taylor G; de Ruiter A. (1 Apr 2011). Atazanavir in pregnancy: a report of 155 cases. HIV MEDICINE. 12:9-10. Author weblink.
  • Elgalib A; Hegazi A; Samarawickrama A; Roedling S; Tariq S; Draeger E; Hemelaar J; Rathnayaka T; et alAzwa A; Hawkins D; Edwards S; Perez K; Russell J; Wood C; Poulton M; Shah R; Noble H; Rodgers M; Taylor GP; Anderson J; de Ruiter A. (1 Feb 2011). Pregnancy in HIV-infected teenagers in London. HIV MEDICINE. 12:118-123. DOI.
  • Hilburn S; Rowan A; Demontis MA; MacNamara A; Asquith B; Bangham CR; Taylor GP. (15 Feb 2011). In vivo expression of human T-lymphotropic virus type 1 basic leucine-zipper protein generates specific CD8+ and CD4+ T-lymphocyte responses that correlate with clinical outcome. J Infect Dis. 203:529-536. DOI.
  • Gillet NA; Malani N; Melamed A; Gormley N; Carter R; Bentley D; Berry C; Bushman FD; et alTaylor GP; Bangham CR. (17 Mar 2011). The host genomic environment of the provirus determines the abundance of HTLV-1-infected T-cell clones. Blood. 117:3113-3122. DOI.
  • Macnamara A; Rowan A; Hilburn S; Kadolsky U; Fujiwara H; Suemori K; Yasukawa M; Taylor G; et alBangham CR; Asquith B. (2010). HLA class I binding of HBZ determines outcome in HTLV-1 infection. PLoS Pathog. 6:e1001117. DOI.
  • Cloke TE; Abebe T; Hailu A; Munder M; Taylor GP; Müller I; Kropf P. (Nov 2010). Antiretroviral therapy abrogates association between arginase activity and HIV disease severity. Trans R Soc Trop Med Hyg. 104:746-748. DOI.
  • Read PJ; Khan P; Mandalia S; Harrisson U; Naftalin C; Gilleece Y; Hawkins D; Anderson J; et alTaylor GP; de Ruiter A. (1 Apr 2010). Achieving an undetectable viral load in pregnancy... Are we starting HAART early enough?. HIV MEDICINE. 11:1-1.
  • Martin F; Fedina A; Youshya S; Taylor GP. (Dec 2010). A 15-year prospective longitudinal study of disease progression in patients with HTLV-1 associated myelopathy in the UK. J Neurol Neurosurg Psychiatry. 81:1336-1340. DOI.
  • Bazarbachi A; Plumelle Y; Carlos Ramos J; Tortevoye P; Otrock Z; Taylor G; Gessain A; Harrington W; et alPanelatti G; Hermine O. (20 Sep 2010). Meta-analysis on the use of zidovudine and interferon-alfa in adult T-cell leukemia/lymphoma showing improved survival in the leukemic subtypes. J Clin Oncol. 28:4177-4183. DOI.
  • Cloke TE; Garvey L; Choi BS; Abebe T; Hailu A; Hancock M; Kadolsky U; Bangham CR; et alMunder M; Müller I; Taylor GP; Kropf P. (15 Aug 2010). Increased level of arginase activity correlates with disease severity in HIV-seropositive patients. J Infect Dis. 202:374-385. DOI.
  • Toulza F; Nosaka K; Tanaka Y; Schioppa T; Balkwill F; Taylor GP; Bangham CR. (1 Jul 2010). Human T-lymphotropic virus type 1-induced CC chemokine ligand 22 maintains a high frequency of functional FoxP3+ regulatory T cells. J Immunol. 185:183-189. DOI.
  • Majorovits E; Nejmeddine M; Tanaka Y; Taylor GP; Fuller SD; Bangham CR. (2008). Human T-lymphotropic virus-1 visualized at the virological synapse by electron tomography. PLOS One. 3:-e2251.
  • Hlela C; Shepperd S; Khumalo NP; Taylor GP. (1 Oct 2009). The Prevalence of Human T-Cell Lymphotropic Virus Type 1 in the General Population is Unknown. AIDS REVIEWS. 11:205-214. Author weblink.
  • de Castro-Costa CM; Campos Araujo ADQ; Camara CC; Ferreira AS; Santos TDJT; de Castro-Costa SB; Alcantara RNM; Taylor GP. (1 Sep 2009). PAIN IN TROPICAL SPASTIC PARAPARESIS/HTLV-I ASSOCIATED MYELOPATHY PATIENTS. ARQUIVOS DE NEURO-PSIQUIATRIA. 67:866-870. Author weblink.
  • Martin F; Taylor GP. (Nov 2009). The safety of highly active antiretroviral therapy for the HIV-positive pregnant mother and her baby: is 'the more the merrier'?. J Antimicrob Chemother. 64:895-900. DOI.
  • Nejmeddine M; Negi VS; Mukherjee S; Tanaka Y; Orth K; Taylor GP; Bangham CRM. (30 Jul 2009). HTLV-1-Tax and ICAM-1 act on T-cell signal pathways to polarize the microtubule-organizing center at the virological synapse. BLOOD. 114:1016-1025. Author weblink DOI.
  • Toulza F; Nosaka K; Takiguchi M; Pagliuca T; Mitsuya H; Tanaka Y; Taylor GP; Bangham CR. (15 Nov 2009). FoxP3+ regulatory T cells are distinct from leukemia cells in HTLV-1-associated adult T-cell leukemia. Int J Cancer. 125:2375-2382. DOI.
  • Kenny J; Evans J; Wankowska H; Gould J; Douglas M; Lyall H; Taylor G; Foster C. (1 Apr 2009). The next generation - a shared care experience of babies born to young women with perinatally acquired HIV-1 infection. HIV MEDICINE. 10:28-29. Author weblink.
  • Elgalib A; Samarawickrama A; Roedling S; Tariq S; Draeger E; Hegazi A; Rathnayaka T; Azwa A; et alHawkins D; Rodgers M; Shah R; Edwards S; Russell J; Noble H; Poulton M; Anderson J; Taylor G; de Ruiter A. (1 Apr 2009). Pregnancies in HIV-infected adolescents: a multicentre descriptive study. HIV MEDICINE. 10:4-4. Author weblink.
  • Goubau P; Wantzin P; Gessain A; Jeannel D; Coste J; Pauli G; vonderHelm K; Bertazzoni U; et alCasoli C; DeRossi A; DelMistro A; Wicks R; Gabutti G; Saracco A; Varnier O; Huisman J; Avillez F; Soriano V; Hatzakis A; Gursevitch V; Horal P; Andersson S; Brewer J; Brennan M; Mortimer P; Tosswill J; Noone A; Patrick H; Weiss R; Weber J; Taylor G. (1 Jan 1996). Seroepidemiology of the human T-cell leukaemia/lymphoma viruses in Europe. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY. 13:68-77. Author weblink.
  • Salemi M; Vandamme AM; Gradozzi C; Van Laethem K; Cattaneo E; Taylor G; Casoli C; Goubau P; et alDesmyter J; Bertazzoni U. (1 May 1998). Evolutionary rate and genetic heterogeneity of human T-cell lymphotropic virus type II (HTLV-II) using isolates from European injecting drug users. JOURNAL OF MOLECULAR EVOLUTION. 46:602-611. Author weblink DOI.
  • Leslie AJ; Pfafferott KJ; Chetty P; Draenert R; Addo MM; Feeney M; Tang Y; Holmes EC; et alAllen T; Prado JG; Altfeld M; Brander C; Dixon C; Ramduth D; Jeena P; Thomas SA; St John A; Roach TA; Kupfer B; Luzzi G; Edwards A; Taylor G; Lyall H; Tudor-Williams G; Novelli V; Martinez-Picado J; Kiepiela P; Walker BD; Goulder PJR. (1 Mar 2004). HIV evolution: CTL escape mutation and reversion after transmission. NATURE MEDICINE. 10:282-289. Author weblink DOI.
  • Sathia L; Obiorah I; Taylor G; Kon O; O'Donoghue M; Gibbins S; Walsh J; Winston A. (1 Jul 2008). Concomitant use of nonnucleoside analogue reverse transcriptase inhibitors and rifampicin in TB/HIV type 1-coinfected patients. AIDS RESEARCH AND HUMAN RETROVIRUSES. 24:897-901. Author weblink DOI.
  • de Ruiter A; Mercey D; Anderson J; Chakraborty R; Clayden P; Foster G; Gilling-Smith C; Hawkins D; et alLow-Beer N; Lyall H; O'Shea S; Penn Z; Short J; Smith R; Sonecha S; Tookey P; Wood C; Taylor G. (1 Aug 2008). British HIV Association and Children's HIV Association guidelines for the management of HIV infection in pregnant women 2008. HIV MEDICINE. 9:452-502. Author weblink DOI.
  • Taylor G. (Dec 2007). Molecular aspects of HTLV-I infection and adult T-cell leukaemia/lymphoma. J Clin Pathol. 60:1392-1396. DOI.
  • Kattan T; MacNamara A; Rowan AG; Nose H; Mosley AJ; Tanaka Y; Taylor GP; Asquith B; et alBangham CR. (1 May 2009). The avidity and lytic efficiency of the CTL response to HTLV-1. J Immunol. 182:5723-5729. DOI.
  • Bangham CR; Meekings K; Toulza F; Nejmeddine M; Majorovits E; Asquith B; Taylor GP. (2009). The immune control of HTLV-1 infection: selection forces and dynamics. Front Biosci. 14:2889-2903.
  • Taylor GP; O'Shea S; Mercey D; de Ruiter A. (1 Feb 2009). Zidovudine monotherapy in pregnancy: is it state of the art?. HIV MEDICINE. 10:129-130. Author weblink DOI.
  • Tsukasaki K; Hermine O; Bazarbachi A; Ratner L; Ramos JC; Harrington W; O'Mahony D; Janik JE; et alBittencourt AL; Taylor GP; Yamaguchi K; Utsunomiya A; Tobinai K; Watanabe T. (20 Jan 2009). Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting. J Clin Oncol. 27:453-459. DOI.
  • Read P; Costelloe S; Mullen J; O'Shea S; Lyons F; Hay P; Welch J; Larbalestier N; et alTaylor GP; de Ruiter A. (1 Aug 2008). New mutations associated with resistance not detected following zidovudine monotherapy in pregnancy when used in accordance with British HIV Association guidelines. HIV MEDICINE. 9:448-451. Author weblink DOI.
  • Turner CG; Cohen CE; Sabin CA; Tosswill JH; Best JM; Taylor GP; de Ruiter A; Barlow D; et alSmith NA. (Oct 2008). The seroepidemiology of HTLV-I amongst genitourinary medicine (GUM) attendees in South East London. J Clin Virol. 43:253-254. DOI.
  • Pichler K; Kattan T; Gentzsch J; Kress AK; Taylor GP; Bangham CRM; Grassmann R. (1 May 2008). Strong induction of 4-1BB, a growth and survival promoting costimulatory receptor, in HTLV-1-infected cultured and patients' T cells by the viral tax oncoprotein. BLOOD. 111:4741-4751. Author weblink DOI.
  • Meekings KN; Leipzig J; Bushman FD; Taylor GP; Bangham CR. (Mar 2008). HTLV-1 integration into transcriptionally active genomic regions is associated with proviral expression and with HAM/TSP. PLoS Pathog. 4:e1000027. DOI.
  • Struik SS; Tudor-Williams G; Taylor GP; Portsmouth SD; Foster CJ; Walsh C; Hanley C; Walters S; et alSmith JH; Lyall H. (1 Jan 2008). Infant HIV infection despite "universal'' antenatal testing. ARCHIVES OF DISEASE IN CHILDHOOD. 93:59-61. Author weblink DOI.
  • Toulza F; Heaps A; Tanaka Y; Taylor GP; Bangham CR. (15 May 2008). High frequency of CD4+FoxP3+ cells in HTLV-1 infection: inverse correlation with HTLV-1-specific CTL response. Blood. 111:5047-5053. DOI.
  • Martin F; Taylor GP. (15 Aug 2007). Increased rates of preterm delivery are associated with the initiation of highly active antiretrovial therapy during pregnancy: a single-center cohort study. J Infect Dis. 196:558-561. DOI.
  • Benzie AA; Bansi LK; Sabin CA; Portsmouth S; Hill T; Johnson M; Gilson R; Easterbrook P; et alGazzard B; Fisher M; Orkin C; Dunn D; Delpech V; Taylor GP; Walsh JC; Phillips AN; United Kingdom Collaborative HIV Cohort (CHIC) Study Group. (11 Jul 2007). Increased duration of viral suppression is associated with lower viral rebound rates in patients with previous treatment failures. AIDS. 21:1423-1430. DOI.
  • Zhang Y; Wallace DL; de Lara CM; Ghattas H; Asquith B; Worth A; Griffin GE; Taylor GP; et alTough DF; Beverley PCL; Macallan DC. (1 Jun 2007). In vivo kinetics of human natural killer cells: the effects of ageing and acute and chronic viral infection. IMMUNOLOGY. 121:258-265. Author weblink DOI.
  • Asquith B; Zhang Y; Mosley AJ; de Lara CM; Wallace DL; Worth A; Kaftantzi L; Meekings K; et alGriffin GE; Tanaka Y; Tough DF; Beverley PC; Taylor GP; Macallan DC; Bangham CR. (8 May 2007). In vivo T lymphocyte dynamics in humans and the impact of human T-lymphotropic virus 1 infection. Proc Natl Acad Sci U S A. 104:8035-8040. DOI.
  • Kropf P; Baud D; Marshall SE; Munder M; Mosley A; Fuentes JM; Bangham CR; Taylor GP; et alHerath S; Choi BS; Soler G; Teoh T; Modolell M; Müller I. (Apr 2007). Arginase activity mediates reversible T cell hyporesponsiveness in human pregnancy. Eur J Immunol. 37:935-945. DOI.
  • Natarajan U; Pym A; McDonald C; Velisetty P; Edwards SG; Hay P; Welch J; de Ruiter A; et alTaylor GP; Anderson J. (1 Jan 2007). Safety of nevirapine in pregnancy. HIV MEDICINE. 8:64-69. Author weblink DOI.
  • Mosley AJ; Meekings KN; McCarthy C; Shepherd D; Cerundolo V; Mazitschek R; Tanaka Y; Taylor GP; et alBangham CR. (1 Dec 2006). Histone deacetylase inhibitors increase virus gene expression but decrease CD8+ cell antiviral function in HTLV-1 infection. Blood. 108:3801-3807. DOI.
  • Fox J; Taylor GP; Day S; Parry J; Ward H. (Oct 2006). How safe is safer sex? High levels of HSV-1 and HSV-2 in female sex workers in London. Epidemiol Infect. 134:1114-1119. DOI.
  • Martin F; Navaratne L; Khan W; Sarner L; Mercey D; Anderson J; Noble H; Fakoya A; et alHawkins DA; De Ruiter A; Taylor GP. (1 Oct 2006). Pregnant women with HIV infection can expect healthy survival: three-year follow-up. J Acquir Immune Defic Syndr. 43:186-192. DOI.
  • De Castro-Costa CM; Araujo AQC; Barreto MM; Takayanagui OM; Sohler MP; Da Silva ELM; De Paula SMB; Ishak R; et alRibas JGR; Rovirosa LC; Carton H; Gotuzzo E; Hall WW; Montano S; Murphy EL; Oger J; Remondegui C; Taylor GP. (1 Oct 2006). Proposal for diagnostic criteria of tropical spastic paraparesis/HTLV-I-associated myelopathy (TSP/HAM). AIDS RESEARCH AND HUMAN RETROVIRUSES. 22:931-935. Author weblink.
  • Garvey L; Thomson EC; Taylor GP. (21 Mar 2006). Progressive multifocal leukoencephalopathy: prolonged survival in patients treated with protease inhibitors and cidofovir: a case series. AIDS. 20:791-793. DOI.
  • Taylor GP; Goon P; Furukawa Y; Green H; Barfield A; Mosley A; Nose H; Babiker A; et alRudge P; Usuku K; Osame M; Bangham CR; Weber JN. (2006). Zidovudine plus lamivudine in Human T-Lymphotropic Virus type-I-associated myelopathy: a randomised trial. Retrovirology. 3:63. DOI.
  • Asquith B; Mosley AJ; Heaps A; Tanaka Y; Taylor GP; McLean AR; Bangham CRM. (9 Dec 2005). Quantification of the virus-host interaction in human T lymphotropic virus I infection. RETROVIROLOGY. 2. Author weblink DOI.
  • Taylor GP; Matsuoka M. (5 Sep 2005). Natural history of adult T-cell leukemia/lymphoma and approaches to therapy. Oncogene. 24:6047-6057. DOI.
  • Nejmeddine M; Barnard AL; Tanaka Y; Taylor GP; Bangham CR. (19 Aug 2005). Human T-lymphotropic virus, type 1, tax protein triggers microtubule reorientation in the virological synapse. J Biol Chem. 280:29653-29660. DOI.
  • Barnard AL; Igakura T; Tanaka Y; Taylor GP; Bangham CR. (1 Aug 2005). Engagement of specific T-cell surface molecules regulates cytoskeletal polarization in HTLV-1-infected lymphocytes. Blood. 106:988-995. DOI.
  • Asquith B; Mosley AJ; Barfield A; Marshall SE; Heaps A; Goon P; Hanon E; Tanaka Y; et alTaylor GP; Bangham CR. (May 2005). A functional CD8+ cell assay reveals individual variation in CD8+ cell antiviral efficacy and explains differences in human T-lymphotropic virus type 1 proviral load. J Gen Virol. 86:1515-1523. DOI.
  • Taylor GP. (1 May 2005). Ethics of assisted reproduction for HIV concordant couples. HUMAN REPRODUCTION. 20:1430-1430. Author weblink DOI.
  • Murphy E; Jacobson S; Franchini G; Taylor GP; Hanchard B; Morgan O; Lairmore M. (29 Mar 2005). International Retrovirology Association brings together scientists and clinicians to bridge discoveries about human T-lymphotropic viruses from the laboratory to clinical trials. RETROVIROLOGY. 2. Author weblink DOI.
  • Taylor GP; Bodéus M; Courtois F; Pauli G; Del Mistro A; Machuca A; Padua E; Andersson S; et alGoubau P; Chieco-Bianchi L; Soriano V; Coste J; Ades AE; Weber JN. (1 Jan 2005). The seroepidemiology of human T-lymphotropic viruses: types I and II in Europe: a prospective study of pregnant women. J Acquir Immune Defic Syndr. 38:104-109.
  • Vine AM; Heaps AG; Kaftantzi L; Mosley A; Asquith B; Witkover A; Thompson G; Saito M; et alGoon PK; Carr L; Martinez-Murillo F; Taylor GP; Bangham CR. (15 Oct 2004). The role of CTLs in persistent viral infection: cytolytic gene expression in CD8+ lymphocytes distinguishes between individuals with a high or low proviral load of human T cell lymphotropic virus type 1. J Immunol. 173:5121-5129.
  • Goon PK; Biancardi A; Fast N; Igakura T; Hanon E; Mosley AJ; Asquith B; Gould KG; et alMarshall S; Taylor GP; Bangham CR. (15 Jun 2004). Human T cell lymphotropic virus (HTLV) type-1-specific CD8+ T cells: frequency and immunodominance hierarchy. J Infect Dis. 189:2294-2298. DOI.
  • Mackie NE; Fidler S; Tamm N; Clarke JR; Back D; Weber JN; Taylor GP. (May 2004). Clinical implications of stopping nevirapine-based antiretroviral therapy: relative pharmacokinetics and avoidance of drug resistance. HIV Med. 5:180-184. DOI.
  • Goon PK; Igakura T; Hanon E; Mosley AJ; Barfield A; Barnard AL; Kaftantzi L; Tanaka Y; et alTaylor GP; Weber JN; Bangham CR. (1 Feb 2004). Human T cell lymphotropic virus type I (HTLV-I)-specific CD4+ T cells: immunodominance hierarchy and preferential infection with HTLV-I. J Immunol. 172:1735-1743.
  • Larbalestier N; Mullen J; O'Shea S; Cottam F; Sabin CA; Chrystie IL; Welch J; Zuckerman M; et alHay P; Rice P; Taylor GP; de Ruiter A. (5 Dec 2003). Drug resistance is uncommon in pregnant women with low viral loads taking zidovudine monotherapy to prevent perinatal HIV transmission. AIDS. 17:2665-2667. DOI.
  • Chung HK; Young HA; Goon PKC; Heidecker G; Princler GL; Shimozato O; Taylor GP; Bangham CRM; et alDerse D. (1 Dec 2003). Activation of interleukin-13 expression in T cells from HTLV-1-infected individuals and in chronically infected cell lines. BLOOD. 102:4130-4136. Author weblink DOI.
  • Goon PK; Igakura T; Hanon E; Mosley AJ; Asquith B; Gould KG; Taylor GP; Weber JN; et alBangham CR. (Sep 2003). High circulating frequencies of tumor necrosis factor alpha- and interleukin-2-secreting human T-lymphotropic virus type 1 (HTLV-1)-specific CD4+ T cells in patients with HTLV-1-associated neurological disease. J Virol. 77:9716-9722.
  • Saito M; Braud VM; Goon P; Hanon E; Taylor GP; Saito A; Eiraku N; Tanaka Y; et alUsuku K; Weber JN; Osame M; Bangham CR. (15 Jul 2003). Low frequency of CD94/NKG2A+ T lymphocytes in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis, but not in asymptomatic carriers. Blood. 102:577-584. DOI.
  • Taylor GP. (1 Jun 2003). Debate - View 2: Assisted conception in couples with HIV infection. SEXUALLY TRANSMITTED INFECTIONS. 79:189-190. Author weblink DOI.
  • Taylor GP. (Jun 2003). View 2: Assisted conception in couples with HIV infection. Sex Transm Infect. 79:189-190.
  • Igakura T; Stinchcombe JC; Goon PK; Taylor GP; Weber JN; Griffiths GM; Tanaka Y; Osame M; et alBangham CR. (14 Mar 2003). Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton. Science. 299:1713-1716. DOI.
  • Lyall EGH; Taylor GP; Clarke J; Mclure MO. (1 Mar 2003). Polymerase chain reaction diagnosis of human immunodeficiency virus infection. PEDIATRIC INFECTIOUS DISEASE JOURNAL. 22:295-295. Author weblink.
  • Wimalasundera RC; Larbalestier N; Smith JN; de Ruiter A; Thom SAM; Hughes AD; Poulter N; Regan L; et alTaylor GP. (12 Oct 2002). Pre-eclampsia, antiretroviral therapy, and immune reconstitution. LANCET. 360:1152-1154. Author weblink DOI.
  • Pennington J; Taylor GP; Sutherland J; Davis RE; Seghatchian J; Allain JP; Williamson LM. (15 Jul 2002). Persistence of HTLV-I in blood components after leukocyte depletion. Blood. 100:677-681.
  • Taylor GP; Jungmann E; Mercey D. (May 2002). Hepatoxicity with antiretroviral treatment of pregnant women. Obstet Gynecol. 99:842-843.
  • Goon PK; Hanon E; Igakura T; Tanaka Y; Weber JN; Taylor GP; Bangham CR. (1 May 2002). High frequencies of Th1-type CD4(+) T cells specific to HTLV-1 Env and Tax proteins in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis. Blood. 99:3335-3341.
  • Littleton ET; Man WD; Holton JL; Landon DN; Hanna MG; Polkey MI; Taylor GP. (May 2002). Human T cell leukaemia virus type I associated neuromuscular disease causing respiratory failure. J Neurol Neurosurg Psychiatry. 72:650-652.
  • Dean GL; Edwards SG; Ives NJ; Matthews G; Fox EF; Navaratne L; Fisher M; Taylor GP; et alMiller R; Taylor CB; de Ruiter A; Pozniak AL. (4 Jan 2002). Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy. AIDS. 16:75-83.
  • Jungmann EM; Mercey D; DeRuiter A; Edwards S; Donoghue S; Booth T; Mohan D; Lyall H; et alTaylor GP. (Dec 2001). Is first trimester exposure to the combination of antiretroviral therapy and folate antagonists a risk factor for congenital abnormalities?. Sex Transm Infect. 77:441-443.
  • Andersson S; Gessain A; Taylor GP. (30 Oct 2001). Pooling of samples for seroepidemiological surveillance of human T-cell lymphotropic virus types I and II. Virus Res. 78:101-106.
  • Taylor GP. (30 Oct 2001). The human T-lymphotropic viruses: bench and bedside progress. Virus Res. 78:1-4.
  • Taylor GP. (1 Oct 2001). Abstracts of the HTLV European Research Network meeting, Potsdam, Germany 19-21st May 2000. VIRUS RESEARCH. 78:107-129. Author weblink.
  • Lyall EG; Blott M; de Ruiter A; Hawkins D; Mercy D; Mitchla Z; Newell ML; O'Shea S; et alSmith JR; Sunderland J; Webb R; Taylor GP; British HIV Association. (Oct 2001). Guidelines for the management of HIV infection in pregnant women and the prevention of mother-to-child transmission. HIV Med. 2:314-334.
  • Hanon E; Goon P; Taylor GP; Hasegawa H; Tanaka Y; Weber JN; Bangham CR. (1 Aug 2001). High production of interferon gamma but not interleukin-2 by human T-lymphotropic virus type I-infected peripheral blood mononuclear cells. Blood. 98:721-726.
  • Matutes E; Taylor GP; Cavenagh J; Pagliuca A; Bareford D; Domingo A; Hamblin M; Kelsey S; et alMir N; Reilly JT. (Jun 2001). Interferon alpha and zidovudine therapy in adult T-cell leukaemia lymphoma: response and outcome in 15 patients. Br J Haematol. 113:779-784.
  • Goon PK; Watkins RP; Lyall EG; Parry J; Taylor GP. (Jun 2001). Third trimester screening or safer sex to prevent mother to child transmission of HIV. Sex Transm Infect. 77:226-227.
  • Edwards SG; Larbalestier N; Hay P; de Ruiter A; Welch J; Taylor GP; Easterbrook P. (Apr 2001). Experience of nevirapine use in a London cohort of HIV-infected pregnant women. HIV Med. 2:89-91.
  • Jeffery KJM; Ushiro I; Hall SE; Hanon E; Taylor GP; Elliott T; Bangham CRM. (1 Jan 2001). A novel HLA-A*02 peptide-binding assay for HTLV-I Tax peptides. AIDS RESEARCH AND HUMAN RETROVIRUSES. 17:S60-S60. Author weblink.
  • Taylor GP; Low-Beer N. (2001). Antiretroviral therapy in pregnancy: a focus on safety. Drug Saf. 24:683-702.
  • Taylor GP; Gessain A; Popescu DM; van't Veer MB; Zehender G; Padua E; Soriano V; Andersson S; et alChristiansen CB; Tosswill JHC; Weber JN. (1 Jan 2001). Demographics and survival of the first 100 patients in the HTLV European research network ATLL register. AIDS RESEARCH AND HUMAN RETROVIRUSES. 17:S42-S42. Author weblink.
  • Taylor GP; Gessain A; Popescu DM; van't Veer MB; Zehender G; Padua E; Soriano V; Andersson S; et alChristiansen CB; Tosswill JHC; Weber JN. (1 Jan 2001). Demographics and survival of the first 100 patients in the HTLV European Research Network ATLL register. AIDS RESEARCH AND HUMAN RETROVIRUSES. 17:S69-S69. Author weblink.
  • Hanon E; Goon P; Taylor GP; Hasegawa H; Tanaka Y; Weber JN; Bangham CRM. (1 Jan 2001). High production of interferon-gamma but not interleukin-2 by human T cell lymphotropic virus type I (HTLV-I)-infected peripheral blood mononuclear cells. AIDS RESEARCH AND HUMAN RETROVIRUSES. 17:S27-S27. Author weblink.
  • Tosswill JHC; Taylor GP; Tedder RS; Mortimer PP. (1 Jan 2001). HTLV-I/II associated disease in England and Wales, 1993-2000. AIDS RESEARCH AND HUMAN RETROVIRUSES. 17:S43-S43. Author weblink.
  • Littleton ET; Man WD; Polkey MI; Taylor GP. (1 Jan 2001). Human T-cell leukaemia virus type 1-related myopathy causing respiratory failure. AIDS RESEARCH AND HUMAN RETROVIRUSES. 17:S65-S65. Author weblink.
  • Saito M; Taylor GP; Saito A; Furukawa Y; Usuku K; Weber JN; Osame M; Bangham CR. (Jan 2001). In vivo selection of T-cell receptor junctional region sequences by HLA-A2 human T-cell lymphotropic virus type 1 Tax11-19 peptide complexes. J Virol. 75:1065-1071. DOI.
  • Saito M; Taylor GP; Saito A; Furukawa Y; Usuku K; Weber JN; Osame M; Bangham CRM. (1 Jan 2001). In vivo selection of TCR junctional region sequences by HLAA2/human T cell leukemia virus type-1 (HTLV-1) Tax11-19 peptide complexes. AIDS RESEARCH AND HUMAN RETROVIRUSES. 17:S61-S61. Author weblink.
  • Bobkov AF; Bobkova MR; Bondarenko VO; Pokrovsky VV; Taylor GP. (1 Jan 2001). No proof of HTLV-I/II infection among injecting drug users in Russia. AIDS RESEARCH AND HUMAN RETROVIRUSES. 17:S34-S34. Author weblink.
  • Taylor GP; Goubau P; Coste J; Pauli G; Chieco-Bianchi L; Padua E; Soriano V; Andersson S; et alAdes A; Weber JN. (1 Jan 2001). The HTLV European Research Network International Antenatal Seroprevalence Study (HERNIAS). AIDS RESEARCH AND HUMAN RETROVIRUSES. 17:S9-S9. Author weblink.
  • Pennington J; Sutherland J; Allain JP; Taylor GP; Seghatchian J; Williamson LM. (16 Nov 2000). Human T-cell leukaemia virus I (HTLV-I) removal from blood and platelets by leucocyte depleting (LD) filters, using real-time quantitative PCR. BLOOD. 96:451A-451A. Author weblink.
  • Hanon E; Stinchcombe JC; Saito M; Asquith BE; Taylor GP; Tanaka Y; Weber JN; Griffiths GM; et alBangham CR. (Nov 2000). Fratricide among CD8(+) T lymphocytes naturally infected with human T cell lymphotropic virus type I. Immunity. 13:657-664.
  • Hanon E; Asquith RE; Taylor GP; Tanaka Y; Weber JN; Bangham CR. (1 Nov 2000). High frequency of viral protein expression in human T cell lymphotropic virus type 1-infected peripheral blood mononuclear cells. AIDS Res Hum Retroviruses. 16:1711-1715. DOI.
  • Stainsby CM; Lyall EGH; Taylor GP; Galpin S; Clarke JR; McClure MO; Weber JN. (1 Oct 2000). A significant number of uninfected infants can be HIV RNA (false) positive. AIDS. 14:S132-S132. Author weblink.
  • Asquith B; Hanon E; Taylor GP; Bangham CR. (29 Aug 2000). Is human T-cell lymphotropic virus type I really silent?. Philos Trans R Soc Lond B Biol Sci. 355:1013-1019. DOI.
  • Brook MG; Taylor GP; Dale A; Lyall EG; Tomlinson D. (Jul 2000). Management of HIV and pregnancy in England's North Thames Region 1999: a survey of practice in 21 hospitals. HIV Med. 1:143-147.
  • Taylor GP; Lyall EGH; Back D; Ward C; Tudor-Williams G. (17 Jun 2000). Pharmacological implications of lengthened in-utero exposure to nevirapine. LANCET. 355:2134-2135. DOI.
  • Ades AE; Parker S; Walker J; Edginton M; Taylor GP; Weber JN. (3 Jun 2000). Human T cell leukaemia/lymphoma virus infection in pregnant women in the United Kingdom: population study. BRITISH MEDICAL JOURNAL. 320:1497-1501. Author weblink DOI.
  • Morozov VA; Lagaye S; Taylor GP; Matutes E; Weiss RA. (1 May 2000). Chimeric matrix proteins encoded by defective proviruses with large internal deletions in human T-cell leukemia virus type 1-infected humans. JOURNAL OF VIROLOGY. 74:3933-3940. Author weblink DOI.
  • Furukawa Y; Bangham CR; Taylor GP; Weber JN; Osame M. (May 2000). Frequent reversible membrane damage in peripheral blood B cells in human T cell lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Clin Exp Immunol. 120:307-316.
  • Louisirirotchanakul S; Thongput A; Khamboonruang C; Taylor GP; Kunstadter P; Wasi C. (15 Apr 2000). No evidence of HTLV-I or HTLV-II infection among the Hmong people of northern Thailand or injecting drug users in Bangkok. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES. 23:441-442. Author weblink.
  • Tosswill JHC; Taylor GP; Tedder RS; Mortimer PP. (4 Mar 2000). HTLV-I/II associated disease in England and Wales, 1993-7: retrospective review of serology requests. BRITISH MEDICAL JOURNAL. 320:611-612. Author weblink DOI.
  • Hanon E; Hall S; Taylor GP; Saito M; Davis R; Tanaka Y; Usuku K; Osame M; et alWeber JN; Bangham CRM. (1 Mar 2000). Abundant Tax protein expression in CD4+T cells infected with HTLV-I is prevented by cytotoxic T lymphocytes. LEUKEMIA. 14:547-547. Author weblink.
  • Hanon E; Hall S; Taylor GP; Saito M; Davis R; Tanaka Y; Usuku K; Osame M; et alWeber JN; Bangham CR. (15 Feb 2000). Abundant tax protein expression in CD4+ T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes. Blood. 95:1386-1392.
  • Taylor GP. (1 Dec 1999). Abstracts from the 4th European HTLV Pathogenesis Meeting - Paris, France 9 June, 1999 - Introduction. VIRUS RESEARCH. 65:1-1. Author weblink.
  • Taylor GP; Hall SE; Navarrete S; Michie CA; Davis R; Witkover AD; Rossor M; Nowak MA; et alRudge P; Matutes E; Bangham CR; Weber JN. (Dec 1999). Effect of lamivudine on human T-cell leukemia virus type 1 (HTLV-1) DNA copy number, T-cell phenotype, and anti-tax cytotoxic T-cell frequency in patients with HTLV-1-associated myelopathy. J Virol. 73:10289-10295.
  • Clarke JR; Braganza R; Mirza A; Stainsby C; Ait-Khaled M; Wright A; Lyall H; Parker D; et alMcClure MO; Weber JN; Taylor GP. (Nov 1999). Rapid development of genotypic resistance to lamivudine when combined with zidovudine in pregnancy. J Med Virol. 59:364-368.
  • Taylor GP; Tosswill JH; Matutes E; Daenke S; Hall S; Bain BJ; Davis R; Thomas D; et alRossor M; Bangham CR; Weber JN. (1 Sep 1999). Prospective study of HTLV-I infection in an initially asymptomatic cohort. J Acquir Immune Defic Syndr. 22:92-100.
  • Taylor GP; Lyall EGH; Tudor-Williams G; Regan L; Smith J. (7 Aug 1999). Labour care of women with HIV infection - Article did not highlight current guidelines. BRITISH MEDICAL JOURNAL. 319:381-382. Author weblink.
  • Bobkova MR; Detkova NV; Buravtsova EV; Bondarenko VO; Bobkov AF; Pokrovsky VV; Taylor GP. (1 Aug 1999). Low prevalence of HTLV-I/II infection among HIV-1-infected injecting drug users in Russia. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES. 21:354-354. Author weblink.
  • Louisirirotchanakul S; Beddows S; Cheingsong R; Shaffer N; Mastro TD; Likanonsakul S; Wasi C; Taylor GP; et alWeber JN. (1 Aug 1999). Role of maternal humoral immunity in vertical transmission of HIV-1 subtype E in Thailand. J Acquir Immune Defic Syndr. 21:259-265.
  • Taylor GP; Lyall EG; Mercey D; Smith R; Chester T; Newell ML; Tudor-Williams G. (Apr 1999). British HIV Association guidelines for prescribing antiretroviral therapy in pregnancy (1998). Sex Transm Infect. 75:90-97.
  • Jeffery KJ; Usuku K; Hall SE; Matsumoto W; Taylor GP; Procter J; Bunce M; Ogg GS; et alWelsh KI; Weber JN; Lloyd AL; Nowak MA; Nagai M; Kodama D; Izumo S; Osame M; Bangham CR. (30 Mar 1999). HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. Proc Natl Acad Sci U S A. 96:3848-3853.
  • Clarke JR; Braganza R; Mirza A; Ait-Khaled M; Wright A; Weber JN; McClure MO; Taylor GP. (1 Nov 1998). High frequency of resistance mutations in pregnant women on dual antiretroviral therapy. AIDS. 12:S20-S20. Author weblink.
  • Jungmann E; Mohan D; Mercey D; de Ruiter A; Lyall H; Taylor GP. (1 Nov 1998). Outcome of HIV-1 positive pregnancies in London since the introduction of the ACTG 076 protocol: a retrospective analysis. AIDS. 12:S96-S96. Author weblink.
  • Tosswill JHC; Taylor GP; Clewley JP; Weber JN. (1 Nov 1998). Quantification of proviral DNA load in human T-cell leukaemia virus type I infections. JOURNAL OF VIROLOGICAL METHODS. 75:21-26. Author weblink DOI.
  • Taylor GP. (Oct 1998). Pathogenesis and treatment of HTLV-I associated myelopathy. Sex Transm Infect. 74:316-322.
  • Ait-Khaled M; Lyall EGH; Stainsby C; Taylor GP; Wright A; Weber JN; McClure MO; Tudor-Williams G. (1 Apr 1998). Intrapartum mucosal exposure to human immunodeficiency virus type 1 (HIV-1) of infants born to HIV-1-infected mothers correlates with maternal plasma virus burden. JOURNAL OF INFECTIOUS DISEASES. 177:1097-1100. Author weblink.
  • Lyall EG; Stainsby C; Taylor GP; Ait-Khaled M; Bingham S; Evans JA; Wright A; Weber JN; et alMcClure MO; Walters S; Tudor-Williams G. (24 Jan 1998). Review of uptake of interventions to reduce mother to child transmission of HIV by women aware of their HIV status. BMJ. 316:268-270.
  • Ali M; Taylor GP; Pitman RJ; Parker D; Rethwilm A; Cheingsong-Popov R; Weber JN; Bieniasz PD; et alBradley J; McClure MO. (10 Oct 1996). No evidence of antibody to human foamy virus in widespread human populations. AIDS Res Hum Retroviruses. 12:1473-1483.
  • Taylor GP. (1996). The epidemiology of HTLV-I in Europe. J Acquir Immune Defic Syndr Hum Retrovirol. 13 Suppl 1:S8-14.
  • ALI M; RETHWILM A; CHEINGSONGPOPOV R; WEBER JN; TAYLOR GP; BIENIASZ PD; BRADLEY J; MCCLURE MO. (1 Oct 1995). SEROEPIDEMIOLOGY OF HFV INFECTION. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY. 10:239-239. Author weblink.

Chapters in books

  • Taylor GP. Prevention of in utero and intrapartum HIV Mother to Child Transmission: The safety and efficacy of antiretroviral therapy. In Principles of Perinatal adn Pediatric HIV/AIDS. 1st:338-355. Lala MM (ed); Merchant RH (ed). Jaypee Brothers Medical Publishers (P) Ltd, New Delhi (2012).
  • Taylor GP. The Human T-lymphotropic Viruses. In Principles and practice of clinical virology. 6th:875-896. Zuckerman AJ (ed); Banatvala JE (ed); Griffiths P (ed); Schoub BD (ed); Mortimer P (ed). John Wiley & Sons Ltd, Chichester, UK (21 Jul 2009).
  • Taylor GP. The Human T Cell Lymphotropic Viruses. In Principles and Practice of Clinical Virology 5th Ed. 759-777. Zuckerman (ed); AJ (ed); Banatvala JE (ed); Pattison JR (ed); Griffiths PD (ed); Schoub BD (ed). John Wiley & Sons (May 2004).

Conferences

  • Hodson A; Crichton S; Taylor GP; Fields P. Adult T-cell leukaemia/lymphoma (ATLL) in England 1999-2009-use of zidovudine and interferon-alpha with chemotherapy improves survival. 51st Annual Scientific Meeting of the British-Society-for-Haematology, 4 Apr 2011 - 6 Apr 2011. 153:7-7. WILEY-BLACKWELL (1 Apr 2011). Author weblink.
  • Pollock KM; Montamat-Sicotte D; Cooke G; Kapembwa M; Kon OM; Taylor GP; Lalvani A. POLYFUNCTIONAL T CELLS REVEAL THE SPECTRUM OF TUBERCULOSIS IN HIV CO-INFECTION THROUGH THE IDENTIFICATION OF IMMUNOLOGICAL CORRELATES OF LATENT AND ACTIVE DISEASE. Winter Meeting of the British-Thoracic-Society, 7 Dec 2011 - 9 Dec 2011. 66:A22-A23. B M J PUBLISHING GROUP (1 Dec 2011). Author weblink DOI.
  • Tattermusch S; Skinner J; Chaussabel D; Banchereau J; Berry M; O'Garra A; Taylor G; Bangham C. An interferon signature is associated with disease but not viral containment in chronic infection with the human T-cell lymphotropic virus type 1. Annual Congress of the British-Society-for-Immunology, 6 Dec 2010 - 10 Dec 2010. 131:188-188. WILEY-BLACKWELL PUBLISHING, INC (1 Dec 2010). Author weblink.
  • Pollock K; Montamat-Sicotte D; Cooke G; Kapembwa M; Kon OM; Taylor GP; Lalvani A. Exploring polyfunctional T cells in HIV and Mycobacterium tuberculosis co-infection; multi-colour flow for a multi-faceted problem. Annual Congress of the British-Society-for-Immunology, 6 Dec 2010 - 10 Dec 2010. 131:147-147. WILEY-BLACKWELL PUBLISHING, INC (1 Dec 2010). Author weblink.
  • Bazarbachi A; Plumelle Y; Ramos JC; Tortevoye P; Otrock Z; Taylor G; Gessain A; Harrington WJ; et alPanelatti G; Hermine O. First Line Antiviral Therapy Significantly Improves Survival of Patients with Acute, Chronic and Smoldering ATL: a Worldwide Meta-Analysis. 51st Annual Meeting of the American-Society-of-Hematology, 5 Dec 2009 - 8 Dec 2009. 114:50-50. AMER SOC HEMATOLOGY (20 Nov 2009). Author weblink.
  • Tattermusch S; Bangham C; Chaussabel D; Taylor G; Banchereau J. The HTLV-1 Immune Signature: Identification of an HTLV-1 Specific Transcriptional Fingerprint by Microarray. 14th International Conference on Human Retrovirology HTLV and Related Retroviruses, 1 Jul 2009 - 4 Jul 2009. 25:1287-1287. MARY ANN LIEBERT INC (1 Nov 2009). Author weblink.
  • Rowan A; Macnamara A; Asquith B; Bangham C; Taylor G; Kattan T. Sensitivity and Efficiency of HTLV-1-Specific Cytotoxic T Lymphocytes. 14th International Conference on Human Retrovirology HTLV and Related Retroviruses, 1 Jul 2009 - 4 Jul 2009. 25:1286-1287. MARY ANN LIEBERT INC (1 Nov 2009). Author weblink.
  • Ferreira AF; Rowan A; Bangham CR; Taylor G. Quantification of CD8+ T Cell Responses to HTLV-1: Balance of inflammatory and Antiviral Effects. 14th International Conference on Human Retrovirology HTLV and Related Retroviruses, 1 Jul 2009 - 4 Jul 2009. 25:1286-1286. MARY ANN LIEBERT INC (1 Nov 2009). Author weblink.
  • Fedina A; Taylor G. Risk Factors for UTI in Patients with HAM/TSP. 14th International Conference on Human Retrovirology HTLV and Related Retroviruses, 1 Jul 2009 - 4 Jul 2009. 25:1278-1278. MARY ANN LIEBERT INC (1 Nov 2009). Author weblink.
  • Macnamara A; Rowan A; Asquith B; Bangham C; Taylor G; Kadolsky U. HLA Class I Binding of HBZ is Associated with Reduced HTLV-I Proviral Load and HAM/TSP Prevalence. 14th International Conference on Human Retrovirology HTLV and Related Retroviruses, 1 Jul 2009 - 4 Jul 2009. 25:1258-1259. MARY ANN LIEBERT INC (1 Nov 2009). Author weblink.
  • Martin F; Fedina A; Taylor GP; Youshya S. 10M Timed Walks Deteriorate in Patients with Chronic HAM/TSP by 2 Sec/Y Independent of HTLV-1 Viral Load. 14th International Conference on Human Retrovirology HTLV and Related Retroviruses, 1 Jul 2009 - 4 Jul 2009. 25:1247-1247. MARY ANN LIEBERT INC (1 Nov 2009). Author weblink.
  • Demontis MA; Taylor G. Molecular Diagnosis of ATLL: The Use of Clonality. 14th International Conference on Human Retrovirology HTLV and Related Retroviruses, 1 Jul 2009 - 4 Jul 2009. 25:1234-1234. MARY ANN LIEBERT INC (1 Nov 2009). Author weblink.
  • Nejmeddine M; Lewis PN; Majorovits E; Negi VS; Mukherjee S; Merriman C; Orth K; Tanaka Y; et alTaylor G; Fuller S; Bangham C. HTLV-1 Virological Synapse: Ultrastructure and Role of Tax Protein. 14th International Conference on Human Retrovirology HTLV and Related Retroviruses, 1 Jul 2009 - 4 Jul 2009. 25:1225-1225. MARY ANN LIEBERT INC (1 Nov 2009). Author weblink.
  • Adonis A; Taylor GP. What Can Walking Related Outcome Measures Tell Us about Patients with HAM. 14th International Conference on Human Retrovirology HTLV and Related Retroviruses, 1 Jul 2009 - 4 Jul 2009. 25:1217-1218. MARY ANN LIEBERT INC (1 Nov 2009). Author weblink.
  • Martin F; Adonis A; Fedina A; Gabriel C; Brodnicki E; Taylor GP; Harrison L; Demontis MA. Ciclosporin for the Treatment of Patients with Early or Progressive HAM: 24-Week Data from an Open, Pilot Study. 14th International Conference on Human Retrovirology HTLV and Related Retroviruses, 1 Jul 2009 - 4 Jul 2009. 25:1216-1217. MARY ANN LIEBERT INC (1 Nov 2009). Author weblink.
  • Toulza F; Nosaka K; Taylor GP; Bangham CRM. CCL22 and HTLV-1: A Possible Link between Foxp3+Cells, HTLV-1 Persistence and Disease. 14th International Conference on Human Retrovirology HTLV and Related Retroviruses, 1 Jul 2009 - 4 Jul 2009. 25:1202-1203. MARY ANN LIEBERT INC (1 Nov 2009). Author weblink.
  • MacNamara A; Rowan A; Kadolsky U; Taylor G; Bangham C; Asquith B. HBZ Binding to HLA Class 1 Determines the Outcome of HTLV-1. 14th International Conference on Human Retrovirology HTLV and Related Retroviruses, 1 Jul 2009 - 4 Jul 2009. 25:1201-1202. MARY ANN LIEBERT INC (1 Nov 2009). Author weblink.
  • Simpson S; Thanigaikumar M; Taylor G; Matutes E; Fields P; Devereux S; Ho A; Mufti GJ; et alPagliuca A. Combination chemotherapy with CHOP-daclizumab in HTLV-1 associated adult T-cell leukaemia/lymphoma. 48th Annual Meeting of the American-Society-of-Hematology, 9 Dec 2006 - 12 Dec 2006. 108:778A-778A. AMER SOC HEMATOLOGY (16 Nov 2006). Author weblink.
  • Bazarbachi A; Panelatti G; Ramos JC; Tortevoye P; Otrock Z; Taylor G; Gessain A; Harrington W; et alPlumelle Y; Hermine O. A worldwide meta-analysis on the use of zidovudine and interferon-alpha for the treatment of adult T-Cell leukemia/lymphoma. 49th Annual Meeting of the American-Society-of-Hematology, 8 Dec 2007 - 11 Dec 2007. 110:610A-611A. AMER SOC HEMATOLOGY (16 Nov 2007). Author weblink.
  • Cloke T; Garvey L; Choi B-S; Bangham CRB; Muller I; Taylor G; Kropf P. Arginase-induced L-arginine metabolism in HIV-infected patients. Annual Congress of the British-Society-of-Immunology, 17 Nov 2008 - 21 Nov 2008. 125:133-133. WILEY-BLACKWELL PUBLISHING, INC (1 Dec 2008). Author weblink.
  • Bazarbachi A; Hermine O; Panelatti G; Ramos JC; Tortevoye P; Otrock Z; Taylor G; Gessain A; et alHarrington W; Plumelle Y. A WORLDWIDE META-ANALYSIS ON THE USE OF ZIDOVUDINE AND INTERFERON-ALPHA FOR THE TREATMENT OF ADULT T-CELL LEUKEMIA/LYMPHOMA. 13th Congress of the European-Hematology-Association, 12 Jun 2008 - 15 Jun 2008. 93:311-311. FERRATA STORTI FOUNDATION (1 Jun 2008). Author weblink.
  • Toulza F; Nosaka K; Takiguchi M; Mitsuya H; Taylor GP; Bangham CRM. Control of CTL response to HTLV-1 virus by regulatory T cells in asymptomatic carriers, HAM/TSP patients, and ATL patients. 13th International Conference on Human Retrovirology - HTLV and Related Viruses. 23:583-583. (Apr 2007).
  • Kattan TT; Mosley AAJ; Tanaka YY; Taylor GP; Bangham CRM. The role of T cell costimulatory molecule expression in human T-lymphotropic virus type-1 infection. 13th International Conference on Human Retrovirology - HTLV and Related Viruses. 23:610-610. (Apr 2007).
  • Adonis AB; Taylor GP. Which outcome measures to use for HTLV-1-Associated myelopathy?. 13th International Conference on Human Retrovirology - HTLV and Related Viruses, 21 May 2007 - 25 May 2007. 23:626-627. MARY ANN LIEBERT INC (1 Apr 2007). Author weblink.
  • Barnard AL; Taylor GP; Tanaka Y; Bangham CRM. A gateway to disease: migration of HTLV-1-infected lymphocytes across human brain endothelial cells. Annual Congress of the British-Society-of-Immunology. 120:32-32. (Mar 2007).
  • Kamat AV; Tueger S; Fields P; Taylor GP; Kazmi M. BEAM CAMPATH - a novel conditioning regimen in autologous peripheral blood stem cell transplantation. 32nd Annual Meeting of the European-Group-for-Blood-and-Morrow-Transplantation/22nd Meeting of the EBMT-Nures-Group/5th Meeting of the EMBT-Data-Management-Group, 19 Mar 2006 - 22 Mar 2006. 37:S345-S346. NATURE PUBLISHING GROUP (1 Mar 2006). Author weblink.
  • Taylor GP; Youshya S; Martin F; Fedina A. Therapeutic interventions in HTLV-1-associated myelopathy (HAM). Clinical Neurosciences 2005 Meeting, 7 Sep 2005 - 9 Sep 2005. 77:128-128. B M J PUBLISHING GROUP (1 Jan 2006). Author weblink.
  • Asquith B; Mosley A; Barfield A; Marshall S; Heaps AG; Goon P; Hanon E; Tanaka Y; et alTaylor GP; Bangham CR. Determinants of HTLV-I proviral load and HAM/TSP risk. 12th International Conference on Human Retrovirology - HTLV and Related Viruses, 22 Jun 2005 - 25 Jun 2005. 21:482-482. MARY ANN LIEBERT INC (1 May 2005). Author weblink.
  • Barnard AL; Igakura T; Yuetsu T; Taylor GP; Bangham C. Engagement of specific T cell surface molecules regulates cytoskeletal polarization in HTLV-1-infected lymphocytes during formation of a virological synapse. 12th International Conference on Human Retrovirology - HTLV and Related Viruses. 21:482-483. (May 2005).
  • Heaps AG; Vine AM; Kaftantzi L; Russell R; Witkover A; Asquith B; Mosley A; Goon PK; et alThompson G; Saito M; Carr L; Martinez-Murillo F; Burns G; Hillyard G; Botcherby M; Taylor GP; Freeman T; Campbell D; Bangham C. Gene expression analysis of the T lymphocyte response to HTLV-1. 12th International Conference on Human Retrovirology - HTLV and Related Viruses. 21:483-483. (May 2005).
  • Nejmeddine M; Barnard AL; Taylor GP; Tanaka Y; Bangham CR. HTLV-1 Tax protein triggers microtubule. 12th International Conference on Human Retrovirology - HTLV and Related Viruses, 22 Jun 2005 - 25 Jun 2005. 21:509-510. MARY ANN LIEBERT INC (1 May 2005). Author weblink.
  • Martin F; Fedina A; Taylor GP. Laboratory investigations of Htlv-i positive patients at first clinic visit: A comparison between asymptomatic carriers and patients with Htlv-i associated myelopathy. 12th International Conference on Human Retrovirology - HTLV and Related Viruses. 21:469-469. (May 2005).
  • Asquith BA; Zhang Y; Mosley A; Worth A; Wallace D; Meekings K; Macallan D; Beverley P; et alTanaka Y; Tough D; Taylor GP; Bangham CR. Lymphocyte kinetics in Htlv-i infection. 12th International Conference on Human Retrovirology - HTLV and Related Viruses, 22 Jun 2005 - 25 Jun 2005. 21:454-454. MARY ANN LIEBERT INC (1 May 2005). Author weblink.
  • Ruckes T; Clarke J; Laue T; Grewing T; Taylor GP. Accurate determination of HTLV proviral load by a multiplex one-tube real-time PCR quantitation assay. 11th International Conference on Human Retrovirology: HTLV and Related Viruses. 19:S55-S55. (2003).
  • Asquith BE; Mosley AJ; Goon PK; Heaps AG; Biancardi A; Barfield A; Vine AM; Taylor GP; et alBangham CR. Does the CTL response determine HTLV-I equilibrium proviral load?. 11th International Conference on Human Retrovirology: HTLV and Related Viruses, 9 Jun 2003 - 12 Jun 2003. 19:S38-S38. MARY ANN LIEBERT INC PUBL (1 Jan 2003). Author weblink.
  • Payne LJ; Tosswill JH; Taylor GP; Simms I. HTLV I and II infections in England and Wales 1988-2001. 11th International Conference on Human Retrovirology: HTLV and Related Viruses. 19:S35-S35. (2003).
  • Davison KL; Vickers M; Hewitt P; Harris HE; Ramsay ME; Moore C; Taylor GP. HTLV-I and II in blood donors in England and Wales: The experience so far. 11th International Conference on Human Retrovirology: HTLV and Related Viruses, 9 Jun 2003 - 12 Jun 2003. 19:S36-S37. MARY ANN LIEBERT INC PUBL (1 Jan 2003). Author weblink.
  • Igakura T; Stinchcombe JC; Goon PK; Taylor GP; Weber JN; Griffiths GM; Tanaka Y; Osame M; et alBangham CR. HTLV-I spreads between lymphocytes by virus-induced polarization of the cytoskeleton. 11th International Conference on Human Retrovirology: HTLV and Related Viruses. 19:S15-S15. (2003).
  • Goon PK; Taylor GP; Bangham CR. HTLV-I-specific CD4+ T cells: Immunodominance hierarchy and preferential infection with HTLV-I. 11th International Conference on Human Retrovirology: HTLV and Related Viruses. 19:S9-S9. (2003).
  • Nejmeddine M; Barnard AL; Goon P; Taylor GP; Igakura T; Bangham CR. Mechanisms involved in the spread of HTLV-1 between lymphocytes. 11th International Conference on Human Retrovirology: HTLV and Related Viruses. 19:S37-S37. (2003).
  • Taylor GP; Goon P; Usuku K; Barfield A; Green H; Babiker A; Bangham CR; Weber JN. The bridge study - A double-blind placebo controlled trial of zidovudine plus lamivudine for treatment of patients with HTLV-I-associated myelopathy. 11th International Conference on Human Retrovirology: HTLV and Related Viruses. 19:S13-S14. (2003).
Share this on Delicious
Tweet this
Digg this
Stumble this
Share this on Facebook